FOI release
HSCNI Communications / Exchange Supplies Ltd
Some or all of the information requested may not have been provided because we determined that the request was vexatious.
Case reference FOI2026/00247
Received 4 March 2026
Published 6 May 2026
Request
This is a request under the Freedom of Information Act 2000. Context On 10 July 2025 I made a protected disclosure to MHRA regarding Exchange Supplies Ltd, WDA 50350, reference CEC 227535. My disclosure included Business Central ERP records evidencing 1,179 individual orders of prescription only medicines including Naloxone and sterile water for injection dispatched from unlicensed Romans Building to Health and Social Care Northern Ireland between April 2022 and October 2024 under public health harm reduction contracts. Please provide all recorded information held by MHRA relating to the following: 1. Communications between MHRA and HSCNI regarding Exchange Supplies Ltd * Any communications between MHRA and HSCNI regarding Exchange Supplies Ltd, WDA 50350, or the supply of medicines from Romans Building, Groove Trading Estate, Dorchester DT1 1ST * Any notification sent to HSCNI regarding compliance failures affecting their supply chain * Any response received from HSCNI * Any risk assessment conducted regarding the supply of Naloxone and sterile water for injection from unlicensed premises to HSCNI harm reduction contracts * If no communication was made to HSCNI, confirmation in writing that HSCNI was not notified Formats Please include emails, letters, case management records, notes and internal communications as defined by FOIA s.84.
Response
See attached
Documents
This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.
You can browse our other responses or make a new FOI request.